Epilepsy and Seizure News
Neurofeedback News
What Is Neurofeedback Therapy? -
Neurofeedback is a noninvasive form of therapy that trains the brain to improve various neurological issues, including chronic pain, ADHD, anxiety, depression and PTSD. Using EEG to monitor real-time ...
Can Neurofeedback Effectively Treat ADHD? -
Neurofeedback training is an alternative therapy that uses real-time EEG data to help patients train their brains to improve focus, impulse control, and executive function. Since the 1970s, patients ...
Systematic Review Finds Few Active Controlled Benefits in Athlete Neurofeedback Studies -
A systematic review of 56 athletic neurofeedback studies reveals that while positive outcomes are widely reported, only 18 percent demonstrate benefits over active control groups.
Elite athletes enhance their performance with 'neurofeedback'—and you can get a device for $99 -
When you think of the training tools that professional athletes have at their disposal, high-tech sports equipment and state-of-the-art athletic facilities come to mind. But training for peak ...
What Is Neurofeedback Therapy And How Does It Work? -
Ashwini Nadkarni, M.D., is a board-certified psychiatrist, Assistant Professor at Harvard Medical School and Interim Vice Chair for Faculty Affairs in the Department of Psychiatry at Brigham and Women ...
Medical News Today
PubMed
Beyond Seizure Control: Building the Infrastructure for Disease-Modifying Therapies in Epilepsy -
Rapid advances in disease-modifying therapies (DMTs) for epilepsy, including gene-based therapies, antisense oligonucleotides, and stem cell-derived approaches, are reshaping the treatment landscape. As these therapies move through clinical trials and toward regulatory review, they introduce complex clinical, operational, ethical, and equity considerations that extend well beyond traditional an...
Dopamine D2 receptor signaling alleviates seizure-related neuronal ferroptosis via MARCH8-mediated P2RX7 ubiquitination -
Epilepsy affects over 70 million people worldwide and remains a major cause of morbidity and premature death. Although dopaminergic signaling dysfunction has been implicated in this disorder, its protective mechanisms are not fully understood. Here, we demonstrated that dopamine D2 receptor (D2R) expression is downregulated during seizures and that D2R signaling protects against seizure. We ide...
Untargeted Plasma Metabolomics Reveals Metabolic Alterations Associated With Idiopathic Epilepsy in Dogs -
CONCLUSIONS: These findings provide preliminary evidence of plasma metabolic alterations associated with canine IE and differences between the acute seizure state and the 14-day seizure-free interval. Given the pooled biological design and limited effective sample size, these findings should be considered exploratory and require validation in larger cohorts using individual biological samples.
Real-world antiseizure medication prescribing and treatment pathways in a pediatric health care system -
OBJECTIVE: To characterize antiseizure medication (ASM) selection, subsequent ASM prescribing, and treatment pathways among patients with epilepsy receiving care within a pediatric health care system.
Etiology and geographic variation in acute symptomatic seizure management: An international vignette-based survey -
OBJECTIVE: Acute symptomatic seizures (ASyS) account for nearly half of new onset seizures, but evidence guiding management remains limited. We aimed to characterize international variation in ASyS management across common etiologies.
Ketogenic diet therapy in adolescents and adults with epilepsy: A scoping review of cognitive outcomes -
OBJECTIVE: The ketogenic diet treatment (KDT) is an established non-pharmacological treatment for drug-resistant epilepsy (DRE). However, rigorous research for seizure efficacy based on randomized controlled studies in adolescents and adults remains limited, and cognitive outcomes are rarely assessed using standardized measures.
Science Daily